News & Events
September 14, 2020
The Critical Path Institute: 15 Years of Impact
A catalyst in the development of new tools and approaches to advance regulatory science and medical product development, Tucson-based Critical Path Institute has been leading teams that share data, knowledge and expertise resulting in sound, consensus-based science for more than 15 years. Even through these unprecedented times, C-Path continues to forge ahead, charting new territory and laying the groundwork for innovative drug development that will lead to treatments and cures for patients around the globe.
Presenter: Klaus Romero, MD, MS, FCP, C-Path Chief Science Officer
Part of Arizona Bioscience Week Educational Events | Register for AZBW 2020
October 29, 2019
2019 Annual Meeting and Regulatory Science WorkshopOctober 29, 2019 Crystal Gateway Marriott | Arlington, VA The key objectives of the meeting are: To discuss the proposed strategy for CPAD of developing comprehensive solutions for AD drug development, based on a quantitative understanding of disease progression across the entire AD continuum To review and define a path to advance the progress of......
November 13, 2018
Critical Path for Alzheimer’s Disease 2018 Annual Meeting and Regulatory Science WorkshopNovember 13, 2018 Overview and Objectives: The Critical Path for Alzheimer’s Disease (CPAD) is a public-private partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process leading to treatments for neurodegenerative diseases that progress to dementia with the shared characteristics of Alzheimer disease (AD), the......
April 11, 2018 - April 12, 2018
2018 Annual International Neonatal Scientific WorkshopBethesda North Marriott Hotel & Conference Center, Maryland Agenda – Day 1, April 11, 2018 8:00 am – 12:00 pm INC Hemodynamic Adaptation Workgroup Meeting Heike Rabe and Janis Dionne, co-chairs 8:00 am – 12:00 pm INC BPD Workgroup Meeting Robin Steinhorn and Wolfgang Göpel, co-chairs 12:00 pm – 1:00 pm Lunch 1:00 pm......
September 26, 2017
Coalition Against Major Diseases 2017 Annual Meeting and Regulatory Science WorkshopSeptember 26, 2017 Overview and Objectives: The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase the efficiency of the development process of new treatments for Alzheimer disease (AD) and related dementias. The annual meeting, which is open to the public, brings......